Evaluation study of diagnostic efficacy in malignant tumors using 11C-methionine PET/CT

Evaluation study of diagnostic efficacy in malignant tumors using 11C-methionine PET/CT - Diagnostic efficacy of 11C-methionine PET/CT for malignant tumors.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002048

Enrollment

1500

Registered

2009-06-06

Start date

2007-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumor

Interventions

11C-methionine PET/CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following conditions.1. Malignant tumor of either brain, mediastinum, lung, or urinary tract2. Surgery is planned 3. Medically fits for surgery4. Written informed consent obtained.

Exclusion criteria

Exclusion criteria: Patients who meet at least one of the following conditions.1. Malignant tumor of neiother brain, mediastinum, lung, nor urinary tract.2. Medically unfit for surgery or suegery not planned.3. Informed consent not given.

Design outcomes

Primary

Measure	Time frame
Concordance with histological diagnosis of surgical specimen. Concordance of clinical stage with postsurgical stage.	—

Countries

Japan

Contacts

Public ContactIchiei Kuji

Saitama Medical University International Medical Center Clinical Trial Support Center

chikens@saitama-med.ac.jp042-984-4523

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026